🇺🇸 FDA
Patent

US 12414963

Treatment of sleep-wake disorders and neurodegenerative disease comprising modified resistant maltodextrin

granted A61KA61K31/716A61K31/718

Quick answer

US patent 12414963 (Treatment of sleep-wake disorders and neurodegenerative disease comprising modified resistant maltodextrin) held by Northwestern University expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/716, A61K31/718, A61P, A61P25/00